Highly active antiretroviral therapy
The South African Health Products Regulatory Authority (SAHPRA) has approved an HIV prevention jab that provides six months of protection at a time, paving the way for a limited public sector rollout in April 2026. The "game-changing" shot, which contains the antiretroviral drug lenacapavir, has been hailed as
HIV
New figures from the UK Health Security Agency show that 2,773 people were newly diagnosed with HIV in England in 2024, a decline of two percent from 2,838 in 2023. However, the number of new diagnoses in some areas, such as Sheffield, increased, with 32 new cases in
Diseases
Researchers from the Centers for Disease Control and Prevention (CDC) have announced a new HIV preexposure prophylaxis (PrEP) option that has shown high efficacy and safety in US clinical trials. According to the CDC, the injectable medication, lenacapavir (LEN), administered every 6 months, has been approved by the Food and
HIV
Health authorities in Sri Lanka are sounding the alarm as over 150,000 individuals engage in high-risk sexual and drug-related behaviors, with experts warning of a potential sharp rise in HIV and sexually transmitted infections (STIs) without immediate intervention. The National STD/AIDS Control Programme has identified 127,511 high-risk
HIV
NHS England has announced its intention to offer the first long-acting injectable form of pre-exposure prophylaxis (PrEP) for individuals who cannot take oral tablets, marking a significant step towards reducing HIV transmission. This move follows the release of the UK Health Security Agency's 2024 HIV surveillance data, which
HIV
Health authorities in Sri Lanka are sounding the alarm as over 150,000 individuals engage in high-risk sexual and drug-related behaviors, with experts warning of a potential sharp rise in HIV and sexually transmitted infections (STIs) without immediate intervention. The National STD/AIDS Control Programme has identified 127,511 high-risk
HIV
The World Health Organization (WHO) and UNAIDS Asia-Pacific have sounded the alarm on the sharp increase in human immunodeficiency virus (HIV) cases in the Philippines, Fiji, and Papua New Guinea. The statistics are alarming, with new infections in Fiji increasing tenfold over the past decade, and a massive spike in
HIV
The World Health Organization (WHO) and UNAIDS Asia-Pacific have sounded the alarm on the sharp increase in human immunodeficiency virus (HIV) cases in the Philippines, Fiji, and Papua New Guinea. The statistics are alarming, with new infections in Fiji increasing tenfold over the past decade, and a massive spike in
HIV
The European region, which stretches from western Europe to central Asia, has seen a significant increase in HIV-related deaths, with 51,000 deaths reported in 2022, a 37% rise from 2010 levels. This is in stark contrast to the global trend, where deaths have halved since 2010. The UNAIDS targets
HIV
The European region, which stretches from western Europe to central Asia, has seen a significant increase in HIV-related deaths, with 51,000 deaths reported in 2022, a 37% rise from 2010 levels. This is in stark contrast to the global trend, where deaths have halved since 2010. The UNAIDS targets
HIV
The European region, which stretches from western Europe to central Asia, has seen a significant increase in HIV-related deaths, with 51,000 deaths reported in 2022, a 37% rise from 2010 levels. This is in stark contrast to the global trend, where deaths have halved since 2010. The UNAIDS targets
HIV
In a landmark study conducted at the Mildmay-Uganda Hospital from 2018 to 2023, researchers analyzed data from 235 people living with HIV (PLHIV) and found that early drug resistance mutations testing and individualized antiretroviral therapy (ART) can significantly improve HIV treatment outcomes. The study, led by Collins Ankunda and colleagues,
